Patanjali Ayurved Limited

24 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• LIST INGRE5 refused lines

  Ingredients not listed

  The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

• NUTRIT LBL5 refused lines

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• SUPPL GMP4 refused lines

  Dietary supplement CGMP not met

  The product appeared to be a dietary supplement prepared, packed, or held under conditions that do not meet current good manufacturing practice (CGMP) regulations.

• UNAPPROVED4 refused lines

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

• UNSAFE ADD4 refused lines

  Food additive unsafe under section 409

  The product appeared to contain a food additive that is unsafe within the meaning of section 409 of the FD&C Act, the section that governs which food additives may be used and under what conditions.

• ALLERGEN2 refused lines

  Major food allergen not declared

  The label appeared not to declare all major food allergens present in the product, as section 403(w) of the FD&C Act requires.

• HEALTH C2 refused lines

  Unauthorized nutrient content or health claim

  The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.

• LACKS N/C2 refused lines

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

Questions about Patanjali Ayurved Limited

Is Patanjali Ayurved Limited on an FDA import alert?

Yes. As of October 26, 2026, Patanjali Ayurved Limited is on the red list of FDA Import Alert 54-14, “Supplements from firms not meeting supplement GMP”, for vitamins/minerals (human/animal); proteins/unconv dietary supp (human); FDA published the listing on April 6, 2015.

Has FDA refused shipments from Patanjali Ayurved Limited?

Yes. FDA refused 21 shipment lines from Patanjali Ayurved Limited between January 15, 2019 and May 6, 2026. The most recent, on May 6, 2026, was herbals & botanicals (not teas), n.e.c., charged as SUPPL GMP (dietary supplement cgmp not met).

Why did FDA refuse Patanjali Ayurved Limited's shipments?

The most frequent charges are LIST INGRE (ingredients not listed, 5 lines) and NUTRIT LBL (nutrition information missing from label, 5 lines).

When was Patanjali Ayurved Limited last inspected by FDA?

FDA's most recent inspection of Patanjali Ayurved Limited with a final classification is dated September 30, 2021 and was classified OAI (Official Action Indicated).

What is Patanjali Ayurved Limited's FEI number?

Patanjali Ayurved Limited's FDA Establishment Identifier (FEI) is 3008068944.

Can shipments from Patanjali Ayurved Limited still enter the U.S.?

Shipments of vitamins/minerals (human/animal); proteins/unconv dietary supp (human) from Patanjali Ayurved Limited can be detained without physical examination under Import Alert 54-14; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).